Are you looking for an effective treatment for pain and inflammation? Look no further than Cataflam®! Manufactured by Novartis, Cataflam is a non-steroidal anti-inflammatory drug (NSAID) that provides relief from various acute conditions. In this blog post, we’ll explore the composition, indications, dosage, precautions, and more about this trusted medication. Let’s dive in and discover how Cataflam can help you manage your pain and inflammation.
Composition and Pharmaceutical Form
Cataflam is available in the form of sugar-coated tablets. Each tablet contains the active substance diclofenac potassium, which is an acetic acid derivative and a related substance. The concentration of diclofenac potassium in each Cataflam sugar-coated tablet is 50 mg.
The composition of Cataflam tablets includes the following:
- Active Substance: Diclofenac potassium (50 mg)
- Excipients: Magnesium stearate, povidone, anhydrous colloidal silica, sodium starch glycolate (type A), maize starch, calcium phosphate, microcrystalline cellulose
- Sugar-coating: Macrogol 6000, hypromellose, talc, titanium dioxide (E171), red iron oxide (E172), and black iron oxide (E172)
Please note that the availability of certain dosage strengths may vary between countries.
Indications
Cataflam is indicated for the short-term treatment of the following acute conditions:
- Post-traumatic pain, inflammation, and swelling (e.g., sprains)
- Post-operative pain, inflammation, and swelling (e.g., dental or orthopedic surgery)
- Painful and inflammatory conditions in gynecology (e.g., primary dysmenorrhea or adnexitis)
- Migraine attacks
- Painful syndromes of the vertebral column
- Non-articular rheumatism
- Severe painful inflammatory infections of the ear, nose, or throat (e.g., pharyngotonsillitis, otitis)
It’s important to note that Cataflam should be used for short-term treatment, and the underlying disease should be treated with appropriate basic therapy. Fever alone is not an indication for Cataflam use.
Dosage and Administration
The dosage of Cataflam should be individually adjusted based on the patient’s condition. It’s recommended to use the lowest effective dose for the shortest duration necessary to control symptoms. Here are the general dosage guidelines:
- General Target Population: The recommended initial daily dose is 75 to 150 mg, divided into 2 or 3 separate doses. In primary dysmenorrhea, the daily dose is usually 50 to 150 mg, and treatment should be started at the first symptoms.
- Migraine: An initial dose of 50 mg should be taken at the first signs of an impending attack. If necessary, a further dose of 50 mg may be taken if relief is not achieved within 2 hours, with a maximum daily dose of 200 mg.
Dosage recommendations may vary for special populations, such as children, adolescents, geriatric patients, and those with renal or hepatic impairment. It’s important to consult a healthcare professional for specific dosing instructions in these cases.
Precautions and Possible Side Effects
Before using Cataflam, it’s important to consider the following precautions:
- Gastrointestinal Effects: Cataflam can cause gastrointestinal disorders such as gastric or intestinal ulceration, bleeding, or perforation. The risk is higher in the elderly and patients with a history of ulcer. Combining Cataflam with protective agents or other NSAIDs should be considered to reduce the risk of gastrointestinal toxicity.
- Cardiovascular Risk: Cataflam may increase the risk of cardiovascular events, especially when used at high doses and for long-term treatment. It’s not recommended for patients with established cardiovascular disease or uncontrolled hypertension.
- Respiratory Effects: Cataflam may cause respiratory reactions in patients with asthma or allergic rhinitis-like symptoms. Precaution is advised in such patients.
- Hepatic and Renal Impairment: Caution is necessary when administering Cataflam to patients with hepatic or renal impairment. Regular monitoring of liver and kidney function is recommended.
- Hypersensitivity: Cataflam should not be used in patients with known hypersensitivity to diclofenac or any of the other excipients.
Adverse drug reactions may occur with Cataflam use. The most common side effects include headache, dizziness, and gastrointestinal disorders. Serious adverse events, although rare, may include thrombocytopenia, leukopenia, anemia, hypersensitivity reactions, and hepatic or renal impairment. If any unexpected symptoms occur, it’s important to seek medical attention.
Drug Interactions and Storage
Cataflam may interact with other medications and substances. It’s important to inform your healthcare provider about all the medications you are taking. Some notable interactions include:
- Potent CYP2C9 Inhibitors: Co-administration of Cataflam with potent CYP2C9 inhibitors should be approached with caution due to the potential increase in plasma concentrations of diclofenac.
- Quinolones and NSAIDs: Concomitant use of quinolones and NSAIDs, including Cataflam, may increase the risk of seizures.
- Selective Serotonin Reuptake Inhibitors (SSRIs): The combination of systemic NSAIDs and SSRIs may increase the risk of gastrointestinal bleeding.
Cataflam should be stored according to the instructions provided on the packaging. It should be kept out of the reach and sight of children.
Conclusion
Cataflam, manufactured by Novartis, is a reliable NSAID that provides effective relief from pain and inflammation associated with various acute conditions. By understanding the composition, indications, dosage, precautions, and possible side effects, you can make informed decisions about the use of Cataflam. However, it’s essential to consult a healthcare professional for personalized advice and guidance regarding your specific condition.
Remember, your health is important, and using medications correctly plays a crucial role in managing your well-being. When used appropriately and under the supervision of a healthcare professional, Cataflam can be a valuable tool in relieving pain and inflammation, helping you get back to feeling your best.
